Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04508140
Status:
TERMINATED
Last Update Posted:
2022-12-13
First Post:
2020-08-05
Brief Title:
Study of BO-112 With Pembrolizumab for Colorectal or GastricGEJ Cancer With Liver Metastasis
Sponsor:
Highlight Therapeutics
Organization:
Highlight Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Colorectal Cancer |
| Gastric Cancer |
| Oesophageal Cancer |
Keywords: